Pharmacological inhibition of EZH2 as a promising differentiation therapy in embryonal RMS.
Ciarapica R, Carcarino E, Adesso L, De Salvo M, Bracaglia G, Leoncini PP, Dall'agnese A, Verginelli F, Milano GM, Boldrini R, Inserra A, Stifani S, Screpanti I, Marquez VE, Valente S, Mai A, Puri PL, Locatelli F, Palacios D, Rota R.
Ciarapica R, et al. Among authors: locatelli f.
BMC Cancer. 2014 Feb 27;14:139. doi: 10.1186/1471-2407-14-139.
BMC Cancer. 2014.
PMID: 24575771
Free PMC article.